SCHEMBL10209490

SCHEMBL10209490

CN(C)CCN(C)C(=O)Cn1cc(C(=O)N2CCC(c3ccccc3C(F)(F)F)CC2)c2ccc(Cl)cc21

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 15/20 0.51
AVPR1A P37288 4/20 0.48
CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL614129 0.92 AVPR1A (0.57) RBP4AVPR1ACNR1
SCHEMBL614574 0.88 AVPR1A (0.60) RBP4AVPR1ACNR1
SCHEMBL613346 0.87 RBP4 (0.56) RBP4
SCHEMBL612849 0.86 RBP4 (0.56) RBP4
SCHEMBL614775 0.85 RBP4 (0.53) RBP4AVPR1ACNR1
SCHEMBL614158 0.84 AVPR1A (0.58) RBP4AVPR1ACNR1
SCHEMBL613550 0.83 RBP4 (0.54) RBP4AVPR1A
SCHEMBL614646 0.82 RBP4 (0.50) RBP4AVPR1ACNR1
Hydrochloric Acid SCHEMBL614973 0.82 RBP4 (0.53) RBP4AVPR1ACNR1
Hydrochloric Acid SCHEMBL614718 0.81 RBP4 (0.49) RBP4AVPR1ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040990-A1 INDOL-3-Y-CARBONYL-PIPERIDIN AND PIPERAZIN-DERIVATIVES BISSANTZ CATERINA (FR) 2012-02-16 US disclosed
US-20120040990-A1 INDOL-3-Y-CARBONYL-PIPERIDIN AND PIPERAZIN-DERIVATIVES BISSANTZ CATERINA (FR) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040990-A1 INDOL-3-Y-CARBONYL-PIPERIDIN AND PIPERAZIN-DERIVATIVES AVPR1A, AVPR2, OXTR RBP4 4183/4885AVPR1A 1/4885CNR1 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.